Table 2.
The first 20 key targets of LGZG decoction in treating hyperlipidemias.
| No. | Target name | Betweenness centrality | Closeness centrality | Degree |
|---|---|---|---|---|
| 1 | TNF | 0.1205 | 0.7204 | 41 |
| 2 | AKT1 | 0.1198 | 0.7053 | 40 |
| 3 | PPARG | 0.1057 | 0.6907 | 38 |
| 4 | PPARA | 0.0951 | 0.6569 | 33 |
| 5 | IL1B | 0.0514 | 0.6505 | 32 |
| 6 | PTGS2 | 0.0414 | 0.6091 | 28 |
| 7 | RXRA | 0.0320 | 0.6036 | 24 |
| 8 | EGFR | 0.0230 | 0.5877 | 24 |
| 9 | ACE | 0.0371 | 0.5982 | 23 |
| 10 | HMGCR | 0.0370 | 0.5776 | 20 |
| 11 | NR3C1 | 0.0147 | 0.5492 | 20 |
| 12 | ABCA1 | 0.0240 | 0.5678 | 19 |
| 13 | AGT | 0.0320 | 0.5678 | 19 |
| 14 | NR1H3 | 0.0090 | 0.5630 | 18 |
| 15 | IFNG | 0.0144 | 0.5678 | 18 |
| 16 | ESR1 | 0.0104 | 0.5194 | 18 |
| 17 | REN | 0.0139 | 0.5537 | 17 |
| 18 | IL4 | 0.0105 | 0.5583 | 17 |
| 19 | CETP | 0.0142 | 0.5194 | 16 |
| 20 | RXRB | 0.0072 | 0.5276 | 16 |